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Abstract  
Background: Whilst prevention of growth faltering has both short- and  long-term health 
benefits, whether too fast, or accelerated infant growth adversely effects later health 
outcomes is controversial and a major focus of research.  
Summary:  Many observational studies suggest that rapid weight gain in infancy (upward 
centile crossing) increases the long-term risk of obesity and non-communicable disease.  
This association has been seen in infants from low-income and high-income countries, in 
infants born preterm or at term, and those born with normal or low birthweight for gestation.  
Experimental (randomised) studies in both breast-fed and formula-fed infants support a 
causal link between early growth acceleration and infant nutrition and later risk of obesity.   
These observations suggest that strategies to optimize the pattern of infant growth could 
make a major contribution to stemming the current global epidemic of non-communicable 
disease.   
Key Messages:  The optimal pattern of infant weight gain is likely to differ in different 
populations.  The benefits of rapid infant weight gain for later neurodevelopment favours the 
promotion of rapid growth in infants born preterm.  However, growth acceleration in healthy 
infants born at term (either normal or low birthweight for gestation) is likely to have adverse 
effects for long-term health. 
(word count 197) 
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Introduction  
Although growth can be defined most simply as the process of increasing in size, we know 
that growth is much more than a quantitative increase in body mass.  Growth is complex 
interaction of closely regulated genetic, hormonal and environmental factors that prepares an 
organism for survival and reproduction.  As a result, growth is an excellent index of a child’s 
health, and monitoring growth is an essential part of paediatric care.  However, growth is not 
only a marker of the immediate physical and emotional well-being of the child, but has long-
term consequences for health [1].  Poor growth is associated with adverse health outcomes in 
adults [1] and hence prevention of growth faltering, and promotion of recovery from a period 
of poor growth has always been a high clinical priority.  
 
More recently, however, there has been increasing interest in the long-term adverse effects of 
the recovery phase of growth, or ‘catch-up growth’. There is now compelling evidence that 
‘accelerated’ or too fast growth during critical or sensitive windows in early life has 
detrimental effects on long-term health, and particularly the risk of obesity and 
cardiovascular disease (CVD) [2]. The current review will consider this evidence and its 
implications for the health of infants born preterm or at term.   
 
Catch-up Growth or Growth Acceleration? 
‘Catch-up’ growth was first formally described in 1954 by Bauer who noted that children 
recovering from the nephrotic syndrome grew faster than the expected rate of growth 
(reviewed by Tanner [3]).  A similar pattern of growth was observed in children recovering 
from several clinical conditions by Prader in 1963 and this pattern of growth, or ‘catch-up 
growth’, was defined as the acceleration in growth in response to recovery from illness or 
starvation [4].  This concept was extended to include children who were born small for 
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gestational age (SGA) and showed faster post-natal growth, a phenomenon assumed to be 
‘catch-up’ growth as a result of recovery from under-nutrition in-utero [3].   
 
However, early post-natal growth is strongly influenced by genetic factors and infants 
genetically predisposed to a large size, but born to small mothers, show fast post-natal growth 
(and vice-versa).  This re-assortment of growth trajectories occurs soon after birth and had 
been described in earlier animal models.  Walton and Hammond showed in 1938 that foals 
born to smaller Shetland horses crossed with larger Shire horses showed faster post-natal 
growth, but not vice versa (i.e. not if the female was the larger Shire horse) suggesting a 
strong genetic component to post-natal growth (as reviewed [3]). Similarly, in humans, twin 
studies suggest that both weight at age six months and the rate of weight gain in infancy are 
strongly influenced by genetic factors (heritability of 62% and 57% respectively) [5].  
Therefore, faster growth after birth is strongly genetic and does not necessarily imply ‘catch-
up’ growth defined as a faster growth rate following recovery from illness or starvation. 
 
Catch-up growth in order to compensate for a period of growth faltering following adversity, 
occurs in species as diverse as mammals, birds, and fish, as well as in humans.  This pattern 
of growth must therefore be an evolutionary conserved adaptive response [6, 7] whose 
benefits could include faster maturity (and hence greater reproductive success), and greater 
likelihood of survival as a result of a larger size in early life leading to protection from 
predators, infectious disease or starvation [6.7].  However, the observation that neither 
animals, nor humans, grow as fast as they are capable of (e.g. as seen with the high rates of 
growth during catch-up growth) suggests that fast growth must also have a biological cost.  
Therefore, there is likely to be a trade-off with short-term benefits of faster growth rates 
counter-balanced by adverse long-term costs, the concept of ‘grow now pay later’ [6].  
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Importantly, because the adverse effects of faster post-natal growth on obesity, non-
communicable disease and risk of ageing are usually manifest in later life (i.e. after 
reproduction) [2], the costs of fast growth are likely to be under less selective pressure than 
the benefits.  
 
In humans, other than genetic factors, nutrition is a major contributor to the rate of growth, 
particularly in early postnatal life, a critical period of development suggested to strongly 
influence long-term health.  For instance, several studies have shown that formula-fed infants 
grow faster than those breast-fed and this pattern of growth is associated with an increased 
later risk of obesity and CVD [2]. These findings have been confirmed in experimental 
studies which found that infants born preterm (or  SGA at term) and randomly assigned to 
formulas with high protein concentrations had increased risk factors for later CVD (adiposity, 
higher blood pressure, insulin resistance, dyslipidaemia and endothelial dysfunction [2]).  
Based on such findings, we proposed the post-natal ‘Growth Acceleration’ hypothesis [2], 
which suggests that upward centile crossing (for weight or length) could explain, in part, 
adverse long-term effects in infants born SGA (who show upward centile crossing 
immediately after birth) and long-term cardiovascular benefits in infants breast-fed (who are 
relatively undernourished and have slower growth compared to those given formula) [2].  
Importantly, the term ‘Growth Acceleration’ makes no assumption about the causes of faster 
post-natal growth, whether this results from genetic factors, or as a result of recovery from 
illness, or starvation (i.e. ‘catch-up’ growth); or as a consequence of a higher plane of post-
natal nutrition.  Moreover, prevention of growth acceleration does not advocate not 
preventing growth faltering or stunting which are clearly harmful patterns of growth [1].  
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Postnatal Growth Acceleration and Long-term Health 
Evidence that growth in early life can affect long-term health first emerged in the 1930’s 
when McCay showed that rapid post-natal growth in rats increased the risk of chronic disease 
and reduced lifespan by up to 35% (reviewed in [2]).  McCay argued that it is possible that 
rapid growth and longevity are incompatible. 
 
In humans, one of the earliest studies to show adverse effects of growth acceleration found 
that faster weight gain in the first 6 weeks of life increased the risk of obesity 6-8 years later 
[8]. Since this early report, there has been a huge increase in evidence to support the growth 
acceleration concept.  Faster infant growth (upward centile crossing for weight or length) has 
been associated with later obesity in 45/46 studies (summarized in 6 systematic reviews [9-
11]) including an individual-level meta-analysis in 47,661 participants from 10 cohorts [11]. 
These associations are seen in both high-income and low-income countries, for both weight 
gain and linear growth, in infants born preterm or at term, in infants with normal or low 
birthweight for gestation, and in both breast-fed and formula-fed infants [9-11].   
 
Importantly, there are now 5 randomised trials that support a causal link between slower 
infant growth and lower risk of later obesity [9].  These trials found that infants fed formulas 
with a higher protein content (and hence had faster weight gain) had a greater risk of later 
obesity than those given lower protein formulas [9, 12].  Similar benefits of slower infant 
weight gain are seen in breast-fed infants.  A randomised trial of a responsive feeding 
intervention design to reduce over feeding in both breast-fed and formula fed infants showed 
that the intervention successfully reduced the rate of weight gain in the first 6 months but also 
reduced the risk of obesity at 1 year of age, six months after the intervention [13]. These 
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long-term effects of early growth have major implications for the nutritional management of 
infants globally as reviewed below. 
 
Early Growth and the Preterm Infant  
Evidence from experimental (randomised) studies showing that patterns of growth can 
influence long-term health was first obtained in infants born preterm in the 1980’s.  At the 
time, it was recognised that preterm infants required a high protein intake to achieve a post-
natal growth rate closer to the intra-uterine rate of growth of a normal fetus of the same post-
conception age, a goal regarded optimal for short- and long-term health. Subsequently, long-
term follow-up of preterm infants randomised to a high protein formula (for an average of 4 
weeks after birth) demonstrated beneficial effects on brain structure and function up to 16 
years later (including 10% greater volume of the caudate nucleus and higher IQ [14]). Since 
this first large trial, numerous observational studies have demonstrated an association 
between poor growth in preterm infants and impaired long-term neuro-cognitive 
development; although more recent reviews suggest that this concept remains unproven [15].  
 
In contrast to the benefits for neurodevelopment, longer-term follow-up the same preterm 
nutritional trials above suggested that faster post-natal weight gain increased later risk factors 
for CVD, a finding confirmed in numerous observational studies [15,16]. Given that adults 
born preterm are at greater risk of both impaired neurodevelopment and CVD, current 
nutrition policy for preterm infants is therefore based on a risk-benefit analysis.  On balance, 
in view of the widely accepted consensus that supporting optimal neurodevelopment is the 
highest priority, current nutrition policy in preterm infants favours a higher protein intake and 
faster growth in order to improve later cognitive function, irrespective of any increase in 
CVD risk.  However, this consensus is largely based on research focused on infants <31 
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weeks gestation and it is uncertain whether the risk-benefit analysis differs for larger, more 
mature, healthy preterm infants.  Furthermore, the most sensitive window for these effects of 
early nutrition/ growth is unknown and so whether the same nutritional policy should apply 
after discharge remains controversial.  
 
Early Growth and the Term SGA Infant    
In contrast to the consensus for nutritional management of preterm infants, the optimal 
growth/nutritional strategy for term SGA is currently unclear and is likely to differ in 
different populations. In high income countries, faster post-natal growth in SGA infants 
appears to increase the later risk of obesity and CVD [16].  For instance, term SGA infants 
randomly assigned to nutrient-enriched formula that increased weight gain had higher 
diastolic BP at age 6–8 years and, in 2 trials, 18-38% greater fat mass at age 5-8 years than 
controls (as reviewed [9]).  Interestingly, differences in childhood fat mass or blood pressure 
between randomised groups were related to the rate of weight gain in the first 6 months 
suggesting a ‘dose-response’ association between early growth and later CVD risk [9].  These 
effects seem to persist into later life.  For example, SGA infants with faster weight gain in the 
first 3 months of life had lower insulin sensitivity and HDL-cholesterol concentrations, and 
higher triglyceride concentrations, obesity and makers of atherosclerosis at age 18-24 years 
[18].  In contrast, SGA infants who showed no catch-up growth had no adverse programming 
effects, findings similar to data from animal models [19].  Therefore, contrary to previous 
medical and public opinion, promoting catch-up growth by nutritional supplementation in 
SGA infants from high-income countries is unlikely to have any advantages for long-term 
health [20].   
 
9 
 
In contrast to data from richer countries, promotion of faster post-natal growth has been 
shown to reduce morbidity in low birthweight infants from low-income countries [21]. 
However, while prevention of stunting and promotion of linear growth clearly has long-term 
benefits for human capital [1], faster weight gain in infancy is also associated with a greater 
risk of obesity and non-communicable diseases in low-income countries [22].  As a result of 
changes in diet and rise in urbanization, large sections of society in low-income countries are 
at increased risk of obesity and CVD, and so susceptible to programming effects of early 
growth [21]. Therefore, whether post-natal upward centile crossing should be promoted in 
developing countries (as is common in many cultures by using bovine milks or early 
introduction of solid foods) is unknown, but is unlikely to be advantageous in view of the 
well-established benefits of exclusively breast-feeding for 6 months. Consequently, the 
optimal pattern of infant weight gain, and its implications for health throughout life, is 
dependent on different risk-balance considerations in various populations and one size may 
not fit all [21].  Clearly, further research is required in low- and middle-income countries to 
define healthy nutritional practices and patterns of growth, particularly using studies with an 
experimental design to establish causal links between early nutrition and long-term health.   
 (word count 1996) 
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